Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts

• Published in: Molecular psychiatry Vol. 28; no. 5; pp. 1983 - 1994
• Main Authors: Giangreco, Basilio, Dwir, Daniella, Klauser, Paul, Jenni, Raoul, Golay, Philippe, Cleusix, Martine, Baumann, Philipp S., Cuénod, Michel, Conus, Philippe, Toni, Nicolas, Do, Kim Q.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.05.2023; Nature Publishing Group
• Subjects: 13; 38; 38/39; 38/62; 631/378; 692/53/2421; 692/53/2423; Antioxidants; Behavioral Sciences; Biological Psychology; Computer applications; Environmental stress; Fibroblasts; Gene expression; Gene polymorphism; Genotype & phenotype; Glutamate-Cysteine Ligase - genetics; Glutamate-Cysteine Ligase - metabolism; Glutamic acid receptors; Glutathione; Glutathione - metabolism; Humans; Inflammation; Inflammation - metabolism; Medicine; Medicine & Public Health; Mental disorders; N-Methyl-D-aspartic acid receptors; Neurosciences; Oxidants; Oxidation-Reduction; Oxidative stress; Oxidative Stress - genetics; Pharmacotherapy; Psychiatry; Psychosis; Psychotic Disorders - genetics; Psychotic Disorders - metabolism; Risk factors; Schizophrenia; Transcriptome
• ISSN: 1359-4184; 1476-5578; 1476-5578
• DOI: 10.1038/s41380-023-02034-x

In view of its heterogeneity, schizophrenia needs new diagnostic tools based on mechanistic biomarkers that would allow early detection. Complex interaction between genetic and environmental risk factors may lead to NMDAR hypofunction, inflammation and redox dysregulation, all converging on oxidative stress. Using computational analysis, the expression of 76 genes linked to these systems, known to be abnormally regulated in schizophrenia, was studied in skin-fibroblasts from early psychosis patients and age-matched controls ( N  = 30), under additional pro-oxidant challenge to mimic environmental stress. To evaluate the contribution of a genetic risk related to redox dysregulation, we investigated the GAG trinucleotide polymorphism in the key glutathione (GSH) synthesizing enzyme, glutamate-cysteine-ligase-catalytic-subunit ( gclc ) gene, known to be associated with the disease. Patients and controls showed different gene expression profiles that were modulated by GAG- gclc genotypes in combination with oxidative challenge. In GAG- gclc low-risk genotype patients, a global gene expression dysregulation was observed, especially in the antioxidant system, potentially induced by other risks. Both controls and patients with GAG- gclc high-risk genotype ( gclc GAG-HR) showed similar gene expression profiles. However, under oxidative challenge, a boosting of other antioxidant defense, including the master regulator Nrf2 and TRX systems was observed only in gclc GAG-HR controls, suggesting a protective compensation against the genetic GSH dysregulation. Moreover, RAGE (redox/inflammation interaction) and AGMAT (arginine pathway) were increased in the gclc GAG-HR patients, suggesting some additional risk factors interacting with this genotype. Finally, the use of a machine-learning approach allowed discriminating patients and controls with an accuracy up to 100%, paving the way towards early detection of schizophrenia.